Distinguished Scientist, Companion Diagnostics

Merck Merck · Pharma · NJ

Distinguished Scientist/Executive Director to lead Companion Diagnostics (CDx) Development teams, overseeing strategy, development, and execution of CDx projects, including digital pathology. Responsibilities include leading cross-functional teams, supervising staff, partnering with internal stakeholders, identifying novel technologies, preparing regulatory documents, and serving as a subject matter expert in diagnostic development for drug development, primarily in Oncology.

What you'd actually do

  1. Lead cross-functional DxDT including Regulatory, Commercial, Business Development, Project Management, Operations, Clinical Development, Statistics, Bioinformatics, etc. to drive CDx strategy, development and implementation of CDx projects – and associated DP when relevant – for a portfolio of various assets/biomarkers, mainly in the therapeutic area of Oncology
  2. Supervise PhD-/MD-level employees leading and executing diagnostic projects within CDx subteams and coordinating the work conducted with our external Dx partners, including associated DP efforts when needed
  3. Partner with internal stakeholders (e.g. clinical/asset teams, Biomarker Leads, CDx Regulatory, Commercial) to assess DxDT needs and develop strategies to address those needs
  4. Contribute to the selection of appropriate assays, platforms and Dx partners for the execution of biomarker strategies, including overseeing possible design/execution of pilot studies with Dx vendors
  5. Identify and assess novel technologies/platforms with potential for CDx application

Skills

Required

  • PhD
  • Extensive experience with one or more major biomarker platforms (i.e. NGS, IHC, PCR)
  • Knowledge of the discovery, development and application of biomarkers in support of decision making for drug development and as CDx
  • Demonstrated track record in the development and approval of CDx
  • Demonstrated expertise in diagnostic development as evident by peer review publication record, patents, and/or products
  • Demonstrated experience in developing and implementing strategic approaches across functional groups and in conjunction with global pharma teams
  • Demonstrated experience in working with clinical teams to support design, implementation and analysis of clinical trials incorporating key biomarkers in order to yield data that can support CDx development and regulatory submissions
  • Familiarity with requirements for EU IVDR, China HGRAC, Japan PMDA, and other global markets for CDx development/registration
  • Proven decision-making and planning skills
  • High level of verbal and written communication skills including presentation capabilities to senior executives
  • Analytical Thinking
  • Assay
  • Bioanalytical Techniques
  • Biomarker Development
  • Clinical Trials
  • Communication
  • Companion Diagnostics (CDx)
  • Drug Development
  • Innovation
  • Leadership
  • Scientific Leadership
  • Strategic Foresight

Nice to have

  • Experience in both pharma and Dx settings
  • Deep technical knowledge in an area of focus such as circulating tumor DNA (ctDNA), immunohistochemistry/ pathology, digital pathology, etc.
  • Experience directly interfacing in meetings and written documents with global health authorities

What the JD emphasized

  • Demonstrated track record in the development and approval of CDx
  • Demonstrated expertise in diagnostic development as evident by peer review publication record, patents, and/or products